Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03654833
Title Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma (MiST)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Leicester
Indications

malignant mesothelioma

Therapies

Bemcentinib + Pembrolizumab

Rucaparib

Abemaciclib

Atezolizumab + Bevacizumab

Dostarlimab-gxly + Niraparib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.